JP2005531607A5 - - Google Patents

Download PDF

Info

Publication number
JP2005531607A5
JP2005531607A5 JP2004510782A JP2004510782A JP2005531607A5 JP 2005531607 A5 JP2005531607 A5 JP 2005531607A5 JP 2004510782 A JP2004510782 A JP 2004510782A JP 2004510782 A JP2004510782 A JP 2004510782A JP 2005531607 A5 JP2005531607 A5 JP 2005531607A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
group
heteroaryl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004510782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531607A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017518 external-priority patent/WO2003103663A2/en
Publication of JP2005531607A publication Critical patent/JP2005531607A/ja
Publication of JP2005531607A5 publication Critical patent/JP2005531607A5/ja
Withdrawn legal-status Critical Current

Links

JP2004510782A 2002-06-05 2003-06-04 キナーゼ阻害剤として置換ピロリン Withdrawn JP2005531607A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38600202P 2002-06-05 2002-06-05
PCT/US2003/017518 WO2003103663A2 (en) 2002-06-05 2003-06-04 Substituted pyrrolines as kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2005531607A JP2005531607A (ja) 2005-10-20
JP2005531607A5 true JP2005531607A5 (cg-RX-API-DMAC7.html) 2006-06-29

Family

ID=29736129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004510782A Withdrawn JP2005531607A (ja) 2002-06-05 2003-06-04 キナーゼ阻害剤として置換ピロリン

Country Status (9)

Country Link
US (4) US7232906B2 (cg-RX-API-DMAC7.html)
EP (1) EP1513520B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005531607A (cg-RX-API-DMAC7.html)
AT (1) ATE409035T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003240517A1 (cg-RX-API-DMAC7.html)
CA (1) CA2488798A1 (cg-RX-API-DMAC7.html)
DE (1) DE60323749D1 (cg-RX-API-DMAC7.html)
ES (1) ES2312785T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003103663A2 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0116468A (pt) * 2000-12-08 2004-06-29 Ortho Mcneil Pharm Inc Compostos de pirrolina substituìda por indazolila como inibidores de cinase
CA2485527A1 (en) * 2002-05-08 2003-11-20 Janssen Pharmaceutica N.V. Substituted pyrroline kinase inhibitors
ES2312785T3 (es) * 2002-06-05 2009-03-01 Janssen Pharmaceutica Nv Pirrolinas sustituidas utiles como inhibidores de quinasa.
JP2006521386A (ja) * 2003-03-27 2006-09-21 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤である置換ピロリン
US7439363B2 (en) * 2003-06-13 2008-10-21 Janssen Parmaceutica N.V. Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors
WO2005068454A1 (en) 2004-01-19 2005-07-28 Novartis Ag Indolylmaleimide derivatives
DE102004010194A1 (de) * 2004-03-02 2005-10-13 Aventis Pharma Deutschland Gmbh 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
DE102004010207A1 (de) * 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
WO2006034207A2 (en) * 2004-09-17 2006-03-30 Vanderbilt University Use of gsk3 inhibitors in combination with radiation therapies
JP5289769B2 (ja) * 2004-12-08 2013-09-11 ヨハネス、グーテンベルク−ウニフェルジテート、マインツ 3−(インドリル)−4−アリールマレイミド誘導体および脈管形成阻害剤としてのそれらの使用
US20080207594A1 (en) 2005-05-04 2008-08-28 Davelogen Aktiengesellschaft Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
EP2246346B1 (en) 2005-07-11 2012-10-24 Novartis AG Indolylmaleimide derivatives as protein kinase inhibitors
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007041195A2 (en) * 2005-09-29 2007-04-12 Janssen Pharmaceutica N.V. Macroheterocylic compounds as kinase inhibitors
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
BRPI0716615A2 (pt) * 2006-08-23 2013-10-08 Novartis Ag Uso de inibidores de pkc em doenças oculares
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP2010513386A (ja) 2006-12-19 2010-04-30 ノバルティス アーゲー キナーゼ阻害剤としてのインドリルマレイミド誘導体
EP2217231B1 (en) * 2007-12-05 2011-11-30 Johannes Gutenberg-Universität Mainz Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2338486A1 (en) 2009-12-18 2011-06-29 Johannes Gutenberg-Universität Mainz 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma
EP2343291A1 (en) 2009-12-18 2011-07-13 Johannes Gutenberg-Universität Mainz 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
JP2013526542A (ja) 2010-05-12 2013-06-24 アッヴィ・インコーポレイテッド キナーゼのインダゾール阻害薬
EP2474541A1 (en) * 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
US9724331B2 (en) * 2012-12-10 2017-08-08 Centogene Ag Use of maleimide derivatives for preventing and treating leukemia
US9993463B2 (en) 2012-12-10 2018-06-12 Centogene Ag Use of maleimide derivatives for preventing and treating cancer
EP3187495A1 (en) 2015-12-30 2017-07-05 Johannes Gutenberg-Universität Mainz 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment
LT3860998T (lt) 2018-10-05 2024-06-25 Annapurna Bio Inc. Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su apj receptoriaus aktyvumu
WO2020163812A1 (en) 2019-02-08 2020-08-13 Frequency Therapeutics, Inc. Valproic acid compounds and wnt agonists for treating ear disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
GB8904161D0 (en) 1989-02-23 1989-04-05 Hoffmann La Roche Substituted pyrroles
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US5624949A (en) 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
EP1449529B1 (en) 1993-12-23 2010-01-27 Eli Lilly And Company Protein Kinase C Inhibitors
JP3258334B2 (ja) 1996-03-20 2002-02-18 イーライ・リリー・アンド・カンパニー インドリルマレイミドの合成
SE9603283D0 (sv) 1996-09-10 1996-09-10 Astra Ab New compounds
AU2548699A (en) 1998-02-23 1999-09-06 Rei Asakai Cell death inhibitors
HUP0103381A3 (en) 1998-07-30 2002-07-29 Japan Tobacco Inc Disubstituted maleimide compounds and medicinal utilization thereof and the pharmaceutical compositions containing the same
JP2002527419A (ja) 1998-10-08 2002-08-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Gsk−3阻害物質としてのピロール−2,5−ジオン類
CA2417277A1 (en) 2000-07-27 2002-02-07 F. Hoffmann-La Roche Ag 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta.
CN1253449C (zh) 2000-11-07 2006-04-26 诺瓦提斯公司 作为蛋白激酶c抑制剂的吲哚基马来酰亚胺衍生物
BR0116468A (pt) 2000-12-08 2004-06-29 Ortho Mcneil Pharm Inc Compostos de pirrolina substituìda por indazolila como inibidores de cinase
CA2485527A1 (en) 2002-05-08 2003-11-20 Janssen Pharmaceutica N.V. Substituted pyrroline kinase inhibitors
JP2005531609A (ja) 2002-06-05 2005-10-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤としてのシスインドリル−マレイミド誘導体
ES2312785T3 (es) * 2002-06-05 2009-03-01 Janssen Pharmaceutica Nv Pirrolinas sustituidas utiles como inhibidores de quinasa.
JP2006521386A (ja) 2003-03-27 2006-09-21 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤である置換ピロリン
US7439363B2 (en) 2003-06-13 2008-10-21 Janssen Parmaceutica N.V. Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP5269758B2 (ja) 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体
JP2004516314A5 (cg-RX-API-DMAC7.html)
EP2219645A2 (en) Use of crth2 antagonist compounds
JP2005531609A5 (cg-RX-API-DMAC7.html)
WO2009063215A2 (en) Use of crth2 antagonist compounds
JP2004538303A5 (cg-RX-API-DMAC7.html)
RU2011108026A (ru) Комбинированная терапия туберкулеза
TW200522952A (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
CA2563302A1 (en) Combinations of glycopyrrolate and beta2 adrenoceptor agonists
JP2007517807A5 (cg-RX-API-DMAC7.html)
CA2450076A1 (en) Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
TW200927129A (en) Organic compounds
CA2554049A1 (en) Quinoline derivatives for use as mycobacterial inhibitors
JP2013532729A5 (cg-RX-API-DMAC7.html)
JP2007516205A5 (cg-RX-API-DMAC7.html)
JP2009513713A5 (cg-RX-API-DMAC7.html)
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
RU2009148507A (ru) Производное тетрагидроизохинолин-1-она или его соль
CN100398103C (zh) 通过烟碱性受体激动剂和单胺能物质的联合作用治疗情感性精神障碍
WO2006060109B1 (en) 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
JP2003519228A5 (cg-RX-API-DMAC7.html)
EP1621198A3 (en) Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
RU2000101307A (ru) Халконы, обладающие антипролиферативной активностью
JP2006513222A5 (cg-RX-API-DMAC7.html)
JP2007519633A5 (cg-RX-API-DMAC7.html)